Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Cancer 8, 411 (1 June 2008) | doi:10.1038/nrc2414
In Brief
Abstract
Metabolism The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth Firestein, R. et al. PLoS ONE 3, e2020 (2008) Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator Lain, S. et al. Cancer Cell 13, 454–463 (2008) Conflicting data have led to the question of whether sirtuin 1 (SIRT1), thought to be a key mediator of the tumour-suppressive effects of calorie restriction, is an oncogene or a tumour suppressor in vivo. Using the Apcmin/+ mouse model of colon cancer, Firestein and colleagues found that SIRT1 deacetylates β-catenin, preventing its oncogenic activity.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
